Shots: Hologic to acquire Focal for its BioZorb marker, an implantable 3D marker helping surgeons to overcome challenges in breast conserving surgery, or lumpectomy used to mark tumor excision site The acquisition on focus on treating breast cancer patients by improving Qol with 3D indicator at surgical site The US FDA has already granted 510(k) […]Read More
